Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) EBT Margin (2017 - 2025)

Selectis Health's EBT Margin history spans 14 years, with the latest figure at 4.64% for Q3 2025.

  • For Q3 2025, EBT Margin rose 1177.0% year-over-year to 4.64%; the TTM value through Sep 2025 reached 6.16%, up 1471.0%, while the annual FY2024 figure was 12.09%, 1818.0% up from the prior year.
  • EBT Margin for Q3 2025 was 4.64% at Selectis Health, up from 6.48% in the prior quarter.
  • Across five years, EBT Margin topped out at 8.61% in Q2 2022 and bottomed at 39.91% in Q4 2023.
  • The 5-year median for EBT Margin is 14.08% (2024), against an average of 13.54%.
  • The largest annual shift saw EBT Margin plummeted -3270bps in 2023 before it soared 3556bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 19.42% in 2021, then fell by -6bps to 20.6% in 2022, then crashed by -94bps to 39.91% in 2023, then surged by 89bps to 4.36% in 2024, then decreased by -6bps to 4.64% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's EBT Margin are 4.64% (Q3 2025), 6.48% (Q2 2025), and 9.2% (Q1 2025).